Autoimmune mechanisms as the basis for human peripartum cardiomyopathy

@article{Ansari2002AutoimmuneMA,
  title={Autoimmune mechanisms as the basis for human peripartum cardiomyopathy},
  author={A. Ansari and J. Fett and R. Carraway and A. Mayne and N. Onlamoon and J. B. Sundstrom},
  journal={Clinical Reviews in Allergy \& Immunology},
  year={2002},
  volume={23},
  pages={301-324}
}
The etiology and mechanisms of pathogenesis of human peripartum cardiomyopathy (PPCM) remain unknown. The incidence and prevalence of this disease is rare in some parts of the world and more common in others. The purpose of this review is to summarize our current knowledge of the factors that have been entertained which may contribute to the pathogenesis of PPCM with special emphasis on more recent data from our laboratory that provide support to the view that this disease is an autoimmune… Expand
Is peripartum cardiomyopathy an organ-specific autoimmune disease?
TLDR
A more thorough study of the precise nature of the cardiac tissue autoantigens may lead to the identification of the mechanisms of breakdown of self-tolerance and perhaps also the putative etiologic agent(s). Expand
Aetiology and risk factors of peripartum cardiomyopathy: a systematic review.
TLDR
There is a need for large-scale multi-centre epidemiological studies and registries to delineate the aetiology and pathogenesis of Peripartum cardiomyopathy, especially in light of recent studies. Expand
Reviewing peripartum cardiomyopathy: current state of knowledge.
TLDR
An overview on the clinical appearance and management, risk factors and potential pathophysiological mechanisms of PPCM, and pharmacological blockade of prolactin holds the promise of novel, more disease-specific therapy options. Expand
Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection.
TLDR
Although there are several possible mechanisms by which Se could play a role in the pathobiology of PPCM, there is no evidence that Se deficiency is a cause of P PCM or a risk factor for the development ofPPCM in this district of Haiti. Expand
The Role of Genetics in Peripartum Cardiomyopathy
  • Y. Lee, D. Judge
  • Medicine
  • Journal of Cardiovascular Translational Research
  • 2017
TLDR
There is substantial evidence demonstrating that at least 10–15% of affected women have a clear genetic contribution to their condition, and family counseling, cascade phenotypic screening, and clinical genetic testing should be considered among women with PPCM. Expand
Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature.
  • N. Gleicher
  • Medicine
  • American journal of obstetrics and gynecology
  • 2007
TLDR
Recognizing PE-E as a clinical condition that is characterized by autoimmune abnormalities may facilitate earlier and morespecific diagnosis, along with preventive and more specific therapies for women at risk. Expand
Peripartum cardiomyopathy: a comprehensive review.
TLDR
The prognosis is poor in patients with persistent cardiomyopathy and portends worse survival, and early diagnosis and initiation of treatment are essential to optimize pregnancy outcome. Expand
What’s next in peripartum cardiomyopathy investigation?
  • J. Fett
  • Medicine
  • Expert review of cardiovascular therapy
  • 2010
TLDR
At the present time, two hypotheses of etiology are foremost: pregnancy-associated hormonal changes, specifically the role of prolactin (PRL); and viral infection. Expand
[Peripartum cardiomyopathy].
TLDR
The prognosis is poor in patients with persistent cardiomyopathy and portends worse survival, and early diagnosis and initiation of treatment are essential to optimize pregnancy outcome. Expand
Peripartum Cardiomyopathy: Review of the Literature
TLDR
A comprehensive updated review of PPCM is provided covering etiopathogeneses, clinical presentation and diagnosis, as well as pharmacological, perioperative and intensive care management and prognosis, while stressing areas that require further research. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 53 REFERENCES
Contribution of the innate immune system to autoimmune myocarditis: a role for complement
TLDR
These findings provide a mechanism by which activated complement, a key product of the innate immune response, modulates the induction of an autoimmune disease. Expand
Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti.
TLDR
Peripartum cardiomyopathy appears to be relatively common in the Hospital Albert Schweitzer District of Haiti and a core group of patients is identified for ongoing epidemiologic and immunohematologic investigation of risk factors and potential etiologic factors. Expand
Idiopathic postpartum cardiomyopathy: report of a case with special reference to its ultrastructural changes in the myocardium as studies by endomyocardial biopsy.
TLDR
A 30-year-old woman who manifested clinical evidence of idiopathic postpartum cardiomyopathy was reported on and a literature review and two types of peculiar deposits in the myocardial cells were observed, which had a peculiar, fine, fibrous structure. Expand
Myocarditis and long-term survival in peripartum cardiomyopathy.
TLDR
In patients with PPCM, long-term survival is better than has been historically reported, the prevalence of myocarditis is high, and decreased left ventricular stroke work index is associated with worse clinical outcomes. Expand
Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis
TLDR
Results, using the more sensitive technology, showed that microchimerism is a very common event in human liver and supported the thesis that this may contribute to the induction/maintenance of fetal tolerance. Expand
Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review.
TLDR
Peripartum cardiomyopathy is a rare lethal disease about which little is known and diagnosis is confined to a narrow period and requires echocardiographic evidence of left ventricular systolic dysfunction. Expand
The genetic susceptibility to Graves' disease.
  • Y. Tomer, T. Davies
  • Biology, Medicine
  • Bailliere's clinical endocrinology and metabolism
  • 1997
TLDR
Preliminary results are reported which demonstrated that a marker located approximately 25 cM from the TSH receptor gene on chromosome 14q31 is linked to GD and in the same vicinity as the IDDM-11 locus, which may signal the presence of a gene family related to endocrine autoimmunity on chromosome14q31. Expand
Gonadal steroids and immunity.
TLDR
The effects of gonadal steroids on the function of the normal immune system as well as their impact on autoimmune processes are examined and current knowledge of the cellular and molecular mechanisms by which Gonadal Steroid effects on Immunity are explored. Expand
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma
TLDR
The finding that HLA class II compatibility of a child was more common for scleroderma patients than for controls, supports the possibility that microchimerism may be involved in the pathogenesis of sclerodma. Expand
Characterization of Enterovirus Isolates from Patients with Heart Muscle Disease in a Selenium-Deficient Area of China
ABSTRACT An association of enterovirus infection with endemic cardiomyopathy (Keshan disease [KD]) and outbreaks of myocarditis in selenium-deficient rural areas of southwestern China has beenExpand
...
1
2
3
4
5
...